載入...
Thromboresistance Comparison of the HeartMate II Ventricular Assist Device With the Device Thrombogenicity Emulation-Optimized HeartAssist 5 VAD
Approximately 7.5 × 10(6) patients in the US currently suffer from end-stage heart failure. The FDA has recently approved the designations of the Thoratec HeartMate II ventricular assist device (VAD) for both bridge-to-transplant and destination therapy (DT) due to its mechanical durability and impr...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Mechanical Engineers
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4023653/ https://ncbi.nlm.nih.gov/pubmed/24337144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1115/1.4026254 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|